Clinical Development Timeline Agreement for Shiva 102 between CorMedix and Counterparty

Summary

This document outlines the clinical development timeline for the drug candidate Shiva 102, as part of the CorMedix Global Development Plan for Deferiprone. It provides a schedule for upcoming clinical activities and references a more detailed development plan attached as an exhibit. The agreement sets forth the timing and sequence of clinical milestones, with specific details redacted. The parties are obligated to follow this timeline as part of their ongoing collaboration.

EX-10.3 4 v239557_ex10-3.htm EXHIBIT 10.3

Exhibit 5.1 A

Clinical Development Timeline for Shiva 102

The following clinical development timeline provides a detailed timeline for the next *** and general outline for subsequent development. Details of the Development Plan are contained in the CorMedix Global Development Plan for Deferiprone dated as of the effective date of Amendment 3 and attached hereto as Exhibit 5.1 B.

2011
*******
	***
	***
	***
*******
	***
	***
	***
	***
	***
	***
*******
	***
	***
	***
*******
*******
	***
*******
	***
	***

Exhibit 5.1 A

Clinical Development Timeline for Shiva 102

2012
*******
	***
	***
	***
	***
*******
	***
	***
	***
	***
	***
*******
	***
		***
		***
		***
		***
		***
		***